Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-?1a in relapsing-remitting multiple sclerosis
- 1 August 1999
- journal article
- clinical trial
- Published by Wiley in Annals of Neurology
- Vol. 46 (2), 197-206
- https://doi.org/10.1002/1531-8249(199908)46:2<197::aid-ana9>3.0.co;2-p
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Clinical and Magnetic Resonance Imaging Changes Correlate in a Clinical Trial Monitoring Cyclosporine Therapy for Multiple SclerosisJournal of Neuroimaging, 1997
- Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosisNeurology, 1995
- Correlating MRI and clinical disease activity in multiple sclerosisNeurology, 1995
- Interferon beta‐lb in the treatment of multiple sclerosisNeurology, 1995
- Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosisNeurology, 1994
- Chronic systemic high‐dose recombinant interferon alfa‐2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing‐remitting multiple sclerosisNeurology, 1994
- Spinal cord MRI using multi‐array coils and fast spin echoNeurology, 1993
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993
- Systemic lymphoblastoid interferon therapy in chronic progressive multiple Sclerosis. I. Clinical and MRI evaluationNeurology, 1990
- Rating neurologic impairment in multiple sclerosisNeurology, 1983